Results 211 to 220 of about 88,443,616 (268)
Some of the next articles are maybe not open access.
5-Lipoxygenase and atherosclerosis
Current Opinion in Lipidology, 20035-Lipoxygenase (5LO) was recently identified as a gene that makes an important contribution to atherosclerosis in mice and humans, but the underlying mechanism(s) remains unknown.Studies of the 5LO pathway in other disease areas suggest that 5LO could contribute to atherosclerosis at different levels, such as lesion initiation, growth and cellular ...
Margarete, Mehrabian, Hooman, Allayee
openaire +2 more sources
Prostaglandins, Leukotrienes and Essential Fatty Acids, 2003
The initial steps in the biosynthesis of leukotrienes from arachidonic acid are carried out by the enzyme 5-lipoxygenase (5-LO). In intact cells, the helper protein 5-LO activating protein (FLAP) is necessary for efficient enzyme utilization of endogenous substrate.
M, Peters-Golden, T G, Brock
openaire +2 more sources
The initial steps in the biosynthesis of leukotrienes from arachidonic acid are carried out by the enzyme 5-lipoxygenase (5-LO). In intact cells, the helper protein 5-LO activating protein (FLAP) is necessary for efficient enzyme utilization of endogenous substrate.
M, Peters-Golden, T G, Brock
openaire +2 more sources
The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein
Clinical Reviews in Allergy & Immunology, 1999LT enzymology, cell biology, and pharmacology are active areas of significant research. New exciting insights into LT function are undoubtedly forthcoming. LT therapy is now established in asthma treatment regimens. The role of LT therapy in other allergic and inflammatory diseases, however, has yet to be assessed.
R L, Bell, R R, Harris
openaire +2 more sources
Novel 5‐lipoxygenase isoforms affect the biosynthesis of 5‐lipoxygenase products
The FASEB Journal, 20105‐Lipoxygenase (5‐LO) is the essential enzyme for the biosynthesis of leukotrienes, important mediators of inflammation. This study investigated whether variants of 5‐LO exist in human leukocytes. 5‐LO mRNA isoforms that are consistent with alternative splicing were identified by RT‐PCR in a cell line or cell type‐specific pattern.
Luc H, Boudreau +6 more
openaire +2 more sources
Journal of Lipid Mediators and Cell Signalling, 1995
In this article, it has been attempted to review data primarily on the activation of human 5-lipoxygenase, in vitro and in the cell. First, structural properties and enzyme activities are described. This is followed by the activating factors: Ca2+, membranes, ATP, and lipid hydroperoxide.
openaire +3 more sources
In this article, it has been attempted to review data primarily on the activation of human 5-lipoxygenase, in vitro and in the cell. First, structural properties and enzyme activities are described. This is followed by the activating factors: Ca2+, membranes, ATP, and lipid hydroperoxide.
openaire +3 more sources
Biochemistry, 1999
5-Lipoxygenase (5LO) catalyzes the first two steps in the biosynthesis of leukotrienes and lipoxins and has therefore become an important target for pharmacological treatment of inflammatory disorders. Binding of calcium to 5LO was shown using several different approaches. Human recombinant enzyme was expressed in E. coli and purified.
T, Hammarberg, O, Rådmark
openaire +2 more sources
5-Lipoxygenase (5LO) catalyzes the first two steps in the biosynthesis of leukotrienes and lipoxins and has therefore become an important target for pharmacological treatment of inflammatory disorders. Binding of calcium to 5LO was shown using several different approaches. Human recombinant enzyme was expressed in E. coli and purified.
T, Hammarberg, O, Rådmark
openaire +2 more sources
Celecoxib inhibits 5-lipoxygenase
Biochemical Pharmacology, 2008Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor used in the therapy of inflammatory and painful conditions. Various COX-2-independent pharmacological effects, such as a chemo-preventive and tumor-regressive activity have been suggested, but the respective non-COX-2 targets of celecoxib are still a matter of research. We now demonstrate that
Maier, Thorsten +11 more
openaire +2 more sources
Interaction of ceruloplasmin and 5-lipoxygenase
Biochemistry (Moscow), 2010The interaction between ceruloplasmin (CP), the multicopper oxidase of human plasma, and 5-lipoxygenase (5-LO), the key enzyme of leukotriene synthesis, is shown for the first time. By Western-blotting and mass spectrometry of tryptic fragments, it is shown that 5-LO from protein extract of human leukocytes binds with immobilized CP.
A V, Sokolov +4 more
openaire +2 more sources
5‐Lipoxygenase‐activating protein stimulates the utilization of arachidonic acid by 5‐lipoxygenase
European Journal of Biochemistry, 19935‐Lipoxygenase (5‐LO) and its activating protein (FLAP) are both required for cellular leukotriene (LT) synthesis, with 5‐LO catalyzing both the synthesis of (5S)‐5‐hydroperoxy 6,8,11,14‐eicosatetraenoic acid (5‐HPETE) from arachidonic acid and the subsequent synthesis of LTA4 from 5‐HPETE. We have previously expressed both human 5‐LO and human FLAP to
M, Abramovitz +5 more
openaire +2 more sources
Calcium Binding to 5-Lipoxygenase
2002Human 5-lipoxygenase (5L0) catalyzes the rate determining step in the cellular production of leukotrienes and lipoxins and has therefore become an important target for pharmacological treatment of inflammatory disorders (1). Regulation of 5L0 activityin vivois complex and has been shown to involve processes such as translocation to membrane structures,
Tove, Hammarberg +3 more
openaire +2 more sources

